Hepatic vein obstruction is a blockage of the hepatic vein, which carries blood away from the liver.
Hepatic vein obstruction prevents blood from flowing out of the liver and back to the heart. This blockage can cause liver damage. Obstruction of this vein can be caused by a tumor or growth pressing on the vessel, or by a clot in the vessel (hepatic vein thrombosis).
Most often, it is caused by conditions that make blood clots more likely to form, including:
- Abnormal growth of cells in the bone marrow (myeloproliferative disorders)
- Chronic inflammatory or autoimmune diseases
- Inherited (hereditary) or acquired problems with blood clotting
- Oral contraceptives
Hepatic vein blockage is the most common cause of Budd-Chiari syndrome.
- Abdominal swelling or stretching due to fluid in the abdomen
- Pain in the right upper abdomen
- Vomiting blood
- Yellowing of the skin (jaundice)
Treatment varies, depending on the cause of the blockage.
Your health care provider may recommend the following medicines:
- Blood thinners (anticoagulants)
- Clot-busting drugs (thrombolytic treatment)
- Medicines to treat the liver disease, including ascites
Surgery may be recommended. This may involve:
Hepatic vein obstruction can get worse and lead to cirrhosis and liver failure. This can be life threatening.
When to Contact a Medical Professional
Call your provider if:
- You have symptoms of hepatic vein obstruction
- You are being treated for this condition and you develop new symptoms
Budd-Chiari syndrome; Hepatic veno-occlusive disease
Hauser SC. Vascular diseases of the gastrointestinal tract. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 25th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 143.
Valla DC. Vascular disease of the liver. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 10th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 85.
Review Date 4/3/2018
Updated by: Michael M. Phillips, MD, Clinical Professor of Medicine, The George Washington University School of Medicine, Washington, DC. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.